A 21-year-old female patient presented with gradual progressive loss of vision in both eyes of 12 years duration. Funduscopic examination revealed bone-spicule pigmentation and choroidal and retinal pigment epithelium atrophy along the vascular arcades, with macular involvement in both eyes. The patient was diagnosed with pigmented paravenous retinochoroidal atrophy which is rare disease, uncommon in females, more commonly affecting the paravascular fundus. Very few cases of macular involvement have been reported.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333544 | PMC |
http://dx.doi.org/10.4103/0974-620X.149867 | DOI Listing |
Vaccines (Basel)
August 2024
Department of Ophthalmology, National Defense Medical College, 3-2 Namiki, Tokorozawa 359-8513, Saitama, Japan.
The pandemic of COVID-19 caused by the SARS-CoV-2 virus is ongoing and a serious menace to global public health. An ocular manifestation is an initial sign of the infection. To date, a comprehensive immune profile of patients with mild COVID-19 has not been well developed.
View Article and Find Full Text PDFEur J Ophthalmol
August 2024
Department of Ophthalmology, ASST Santi Paolo e Carlo Hospital, University of Milan, Milan, Italy.
Introduction: Concomitant manifestation of PPRCA in one eye and RP-like retinopathy in the fellow eye is a rare clinical entity, with limited published descriptions to date. The aim of this study is to describe comprehensive clinical evaluations and long-term follow-up of three patients affected by this clinical picture.
Methods: Three patients with concurrent PPRCA and RP-like retinopathy were prospectively re-evaluated and comprehensive assessments were performed.
JAMA Ophthalmol
March 2024
Instituto de Microcirugía Ocular, Barcelona, Spain.
Case Rep Ophthalmol
January 2024
Department of Ophthalmology, Osaka University Graduate School of Medicine, Osaka, Japan.
Can J Ophthalmol
June 2024
Kingston Health Sciences Centre, Queen's University, Kingston, ON. Electronic address:
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!